Insider · CIK 0001866024
Gayle Deflin
Files at AMPH (Amphastar Pharmaceuticals, Inc.). First filing Nov 15, 2023, latest Nov 15, 2023.
In brief
Gayle Deflin files SEC Form 4 as director at AMPH (Amphastar Pharmaceuticals, Inc.). Since Nov 15, 2023, Gayle Deflin has reported 0 open-market buys worth $0 and 1 open-market sell worth $231k, the latest filed on Nov 15, 2023.
A track record needs three past buys with six months of prices behind them; Gayle Deflin has 0, so none is measured yet.
The newest scored trade: sold $231k of AMPH on Nov 14, 2023, filed Nov 15, 2023, scored 63 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMPH: Amphastar Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | Amphastar Pharmaceuticals, Inc. | $231k 4,163 shares | -61% | +101% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 13, 2023 | AMPH Amphastar Pharmaceuticals Inc. | 4,163 0.01% of outstanding | $216k | Nov 13, 2023 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | AMPH Amphastar Pharmaceuticals, Inc. | AGrant or award Common Stock | +8,143 | $0.00 | $0 | 19,057 | Jun 3, 2026 |
| Jun 1, 2026 | AMPH Amphastar Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,365 | $0.00 | $0 | 17,365 | Jun 3, 2026 |
| Jun 2, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | AGrant or award Common Stock | +5,122 | $0.00 | $0 | 10,914 | Jun 4, 2025 |
| Jun 2, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,402 | $0.00 | $0 | 11,402 | Jun 4, 2025 |
| Nov 14, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,163 | $55.45 | $231k | 2,716 | Nov 15, 2023 |
Questions about Gayle Deflin
Answered from the filings on this page, as of the latest one.
Is Gayle Deflin buying or selling?
Not in the last 12 months. Gayle Deflin's latest open-market trade on SEC Form 4 was sold $231k of AMPH on Nov 14, 2023.
How did Gayle Deflin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gayle Deflin has 0.
Where does Gayle Deflin file Form 4?
Gayle Deflin has filed Form 4 at AMPH (Amphastar Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.